Search for: "Ambry Genetics" Results 21 - 40 of 42
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Oct 2013, 9:59 pm by Patent Docs
Noonan -- In responding to Myriad Genetics' complaint for patent infringement, both Ambry Genetics and Gene-by-Gene asserted counterclaims under the Sherman Antitrust Act, predicated on Myriad's filing its patent infringement lawsuit. [read post]
23 Oct 2013, 9:56 pm by Patent Docs
Noonan -- On July 19th, Myriad Genetics amended its complaint against Ambry Genetics to include claims to its patents relating to colon cancer predictive genetic diagnostic testing (amended complaint). [read post]
21 Oct 2013, 8:54 pm by Patent Docs
The complaint is similar to Myriad's complaints against Ambry Genetics and Gene-by-Gene, but this time Myriad has added infringement allegations relating to its mutY homolog (MUTYH)... [read post]
13 Oct 2013, 9:54 pm by Patent Docs
This company is thus very different from the more traditional genomics companies like Ambry Genetics, Gene-by-Gene, and Counsyl that... [read post]
9 Oct 2013, 8:12 pm by Patent Docs
Noonan -- Not to be outdone by defendants Ambry Genetics and Gene-by-Gene's 109-page brief in opposition to Myriad's Preliminary Injunction Motion, Myriad has now filed a Reply Brief weighing in at 140 pages (page limits in briefs seemingly unknown in the District of Utah). [read post]
9 Sep 2013, 4:00 am by Courtenay Brinckerhoff
The hearing on Myriad’s motion for a preliminary injunction against Ambry Genetics is scheduled for September 11, 2013, before Judge Robert A. [read post]
29 Aug 2013, 4:00 am by John Willinsky
” This would seem to be the case, and all the more so, when the University of Utah Research Foundation launched patent-infringement suits against Ambry Genetics and Gene by Gene on July 9th and 10th, as these two companies had started to provide women with the genetic tests for breast cancer at greatly reduced prices ($2,280 and $995 respectively). [read post]
28 Aug 2013, 8:57 pm by Patent Docs
Ambry Genetics case, Myriad argues that this legal precedent, as well as the principles first enunciated... [read post]
27 Aug 2013, 9:53 pm by Patent Docs
The amici brief was submitted in support of Ambry Genetics and Gene by Gene, which have opposed Myriad's motion for a preliminary injunction. [read post]
7 Aug 2013, 9:59 pm by Patent Docs
Procedurally, Ambry raised no challenge to jurisdiction or venue, but denied that the named plaintiffs are the owners or co-owners of the asserted patents, and admitted only that it provides genetic diagnostic testing services... [read post]
7 Aug 2013, 6:23 am by Joe Mullin
Just weeks after it lost at the high court, Myriad filed new lawsuits against the first two competitors who began offering BRCA gene testing, Ambry Genetics and Gene by Gene. [read post]
30 Jul 2013, 9:20 pm by Patent Docs
Noonan -- Earlier this month, Myriad Genetics filed patent infringement lawsuits against Ambry Genetics (on July 9th) and Gene-by-Gene (on July 10th). [read post]
20 Jul 2013, 7:27 pm by Mark Summerfield
As has been widely reported, hot on the heels of its ‘loss’ at the US Supreme Court Myriad Genetics has sued Ambry Genetics for infringing 10 patents covering genetic testing for BRCA1 and BRCA2 genes linked to breast and ovarian cancer. [read post]
18 Jul 2013, 12:00 am by Courtenay Brinckerhoff
One of the most interesting arguments that Myriad made in its Motion for Preliminary Injunctive Relief in its infringement action against Ambry Genetics Corporation relates to the database of genetic information that Myriad has developed over its years of conducting BRCA1 and BRCA2  genetic... [read post]
11 Jul 2013, 1:00 am by Courtenay Brinckerhoff
On July 9, 2013, Myriad Genetics, Inc. brought suit against Ambry Genetics Corporation, alleging that Ambry is infringing ten (10) patents by offering breast cancer genetic testing for the BRCA1 and/or BRCA2 mutations associated with aggressive forms of breast and ovarian cancer. [read post]
10 Jul 2013, 9:31 pm by Patent Docs
Noonan -- A day after Myriad Genetics sued Ambry Genetics for patent infringement, the company filed suit in the District of Utah, Central Divisions against Gene by Gene Ltd. [read post]
9 Jul 2013, 9:59 pm by Patent Docs
Ambry Genetics was one of the first companies to announce that it would provide genetic diagnostic testing for the BRCA 1 and BRCA 2 genes on the day the U.S. [read post]
6 Feb 2013, 7:38 am by Robert Cook-Deegan
  This matters in the practical world of gene testing, because firms like Ambry Genetics have introduced tests for inherited risk of breast and ovarian cancer that cover over a dozen genes. [read post]